Overview

Fenofibrate in Patients With Primary Biliary Cholangitis (PBC)

Status:
RECRUITING
Trial end date:
2027-04-01
Target enrollment:
Participant gender:
Summary
An Open Label Long-Term Study to Evaluate the Safety and Effectiveness of Fenofibrate in Subjects with Primary Biliary Cholangitis (PBC)
Phase:
PHASE2
Details
Lead Sponsor:
Xijing Hospital of Digestive Diseases
Treatments:
Fenofibrate